… have emphasized improving access to treatments and accelerating medical innovation. Advancing … light for the treatment of cutaneous T-cell lymphoma (“CTCL”). With … technology, dusquetide (“SGX942”) for the treatment of inflammatory diseases, including oral …

… the treatment of adult patients with relapsed/refractory follicular lymphoma who … by U.S. Food and Drug Administration (FDA) in fifth cancer … .fda.gov/drugs/resources-information-approved-drugs/fda-grants …

… trial for large B-cell lymphoma (LBLC) adjusts protocol: ALPHA3 … therapy for large B-cell lymphoma (LBCL). The company made … setting will simplify study treatment and has the potential … Consolidation for Large B-Cell Lymphoma. Allogene. August 1, 2025 …

… I was diagnosed with follicular lymphoma, a form of blood … problematic assumptions. Because follicular lymphoma is so treatable (for … , people assume that completing treatment comes with relief, and … I was before treatment, and my treatment, compared to a …

… treatment of patients with relapsed/refractory follicular lymphoma … and set a Prescription Drug User Fee Act date … safety, the most common treatment-emergent adverse effects (TEAEs) … for the treatment of relapsed/refractory follicular lymphoma. News …

An expert discusses the transformative impact of CAR T-cell therapy in relapsed/refractory large B-cell lymphoma, highlighting long-term data that support durable remission—and potential cure—for a subset of patients, while emphasizing its favorable …

… therapy for the treatment of large B-cell lymphoma. However, the mortality … prepare patients for cema-cell treatment. According to Allogene’s news … and cyclophosphamide (FC) as lymphodepletion treatments for patients receiving cema-cel …

… delays for blockbuster ophthalmology drug Eylea HD due to … syringe and for the treatment of macular edema following … #47;refractory follicular lymphoma market for the drug, though the Catalent … s billion-dollar weight loss drug Wegovy (semaglutide). Schleifer …

… relapsed diffuse large B-cell lymphoma (DLBCL), an aggressive … the shelf’ Car-T treatment derived from donor cells (rather … advance a US Food and Drug Administration (FDA) marketing application … as Health Check: Cancer drug developers drive further positive …

… adult T-cell leukemia/lymphoma (ATL), an aggressive and often … to turn the tables in treatment." The findings offer hope …